Carboprost Alembic vs Prostinfenem: Side-by-Side Comparison
Quick answer: Carboprost Alembic and Prostinfenem are both prostaglandin f2-alpha analog (uterotonic) used for similar indications. They share a mechanism of action but differ in dosing, half-life, side-effect profile, and clinical preferences. Switching between them is a clinical decision.
Side-by-side comparison
| Feature | Carboprost Alembic | Prostinfenem |
|---|---|---|
| Drug class | Prostaglandin F2-alpha analog (uterotonic) | Prostaglandin F2-alpha analog (uterotonic) |
| ATC code | G02AD04 | G02AD04 |
| Primary indications | Postpartum hemorrhage refractory to oxytocin, Second-trimester abortion | Postpartum hemorrhage, Uterine atony |
| Mechanism | Synthetic 15-methyl prostaglandin F2-alpha that stimulates myometrial contractions via prostaglandin receptors | Carboprost (15-methyl PGF2-alpha) inducing strong uterine contraction via prostaglandin receptors |
| Common dose | 250 mcg IM, may repeat every 15-90 min, max 2 mg total | 0.25 mg IM, repeat every 15-90 min (max 2 mg) |
| Detail page | Carboprost Alembic details → | Prostinfenem details → |
How to choose between Carboprost Alembic and Prostinfenem
Both medicines belong to the same therapeutic class and address overlapping indications. Selection between them depends on:
- Patient-specific factors: age, kidney and liver function, other medications, allergies, comorbidities
- Specific clinical indication: some class members are preferred for particular conditions or guideline recommendations
- Dosing preference: once-daily vs twice-daily, oral vs injectable, food requirements
- Tolerability: individual side-effect profiles vary even within a class
- Drug interactions: patient's other medications may interact differently with each option
- Cost and availability: generic availability, insurance coverage, regional access
Should you switch?
Switching between class members is a clinical decision, not a self-help one. Reasons your prescriber may consider switching include:
- Inadequate response to current medication
- Side effects affecting quality of life
- New drug interactions due to a recently added medication
- Cost or availability changes
- Updated guidelines favoring a different option
Never switch medications, change dose, or stop without consulting your prescriber.
Related
All Prostaglandin F2-alpha analog (uterotonic) on iMedic · Carboprost Alembic full details · Prostinfenem full details
Frequently asked questions
Is Carboprost Alembic better than Prostinfenem?
Neither is universally 'better.' They are both prostaglandin f2-alpha analog (uterotonic) with similar mechanisms of action. The right choice depends on the specific clinical situation, patient factors, dosing preferences, drug interactions, and tolerability. Discuss with your prescriber.
Can I switch from Carboprost Alembic to Prostinfenem?
Switching is possible but should be done under clinical supervision. Different class members may not be interchangeable on a 1:1 dose basis, and tapering or transition strategies vary. Never switch on your own.
Do Carboprost Alembic and Prostinfenem have the same side effects?
They share class-wide side-effect tendencies but differ in individual profiles. Some patients tolerate one better than the other. Specific frequency and severity of side effects can be found on each medicine's individual page.
Are Carboprost Alembic and Prostinfenem available as generics?
Generic availability depends on patent status in your country. Most well-established class members are available generically and are clinically equivalent to brand-name versions.
Last reviewed: by iMedic Medical Editorial Team. Our editorial process.